Organ-specific manifestations of COVID-19 infection

Maria Gavriatopoulou(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(Korea University)

Clinical and Experimental Medicine

July 27, 2020

10.1007/s10238-020-00648-x

Cited by 518

Related Papers

International uniform response criteria for multiple myeloma

|Leukemia|2006|2.6k

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

|Journal of Clinical Oncology|2015|2.2k

Hematological findings and complications of <scp>COVID</scp>‐19

|American Journal of Hematology|2020|1.7k

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

|Journal of Clinical Oncology|2012|965

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

|Leukemia|2007|839